NCT03905421

Quality of Life Assessed With the PAH SYMPACT Questionnaire

Quality of Life Assessed With the PAH SYMPACT Questionnaire in the Pulmonary Hypertension Clinic

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 390 (actual)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Researchers are evaluating quality of life in pulmonary hypertension subjects using the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire and assessing the questionnaires' performance with regard to relationship to other markers of disease severity, response to treatment, and outcome in a clinical practice setting.

Detailed description

Subjects will be recruited from among those seen at the Mayo Pulmonary Hypertension Clinic. The PAH-SYMPACT questionnaire will be administered either in written form or by telephone interview. On the second 100 patients implement a standardized palliative care referral program for patients with Group 1 and 3 PH and high SYMPACT scores\> 1.0.

Conditions

• Pulmonary Hypertension

Timeline

• Start date: 2019-03-06
• Primary completion: 2024-01-22
• Completion: 2024-01-22
• First posted: 2019-04-05
• Last updated: 2025-07-25

Locations

1 site across 1 country: United States